REVERAGEN BIOPHARMA, INC.
This profile is built entirely from public award records. If this is your organisation you can claim it and add a website and a description. Claiming changes nothing about the award figures.
A floor, not a total. These are the federal assistance awards we hold, for the fiscal years imported, under the assistance listings our own records name. Money received outside that window is real and is not here.
By fiscal year
| Fiscal year | Awards | Total |
|---|---|---|
| 2021 | 1 | $1,201,236 |
| 2018 | 1 | $224,998 |
| 2016 | 2 | $9,453,379 |
Who funded them
| Funder | Years | Awards | Total |
|---|---|---|---|
| National Institutes of Health | 2016–2018 | 3 | $9,678,377 |
| Food and Drug Administration | 2021 | 1 | $1,201,236 |
Programmes, and what is open under them now
An assistance listing names a programme, and every year that programme runs carries the same number. The right-hand column is how many opportunities the catalogue currently holds under it — a fact about the catalogue, not a prediction about anybody.
| Listing | Awards | Total | Open now |
|---|---|---|---|
| 93.853 | 2 | $9,453,379 | 101 |
| 93.103 | 1 | $1,201,236 | 55 |
| 93.865 | 1 | $224,998 | 105 |
The awards themselves
Largest first. Every row links to the award record it came from.
| Award | Funder | Source | Listing | FY | Amount |
|---|---|---|---|---|---|
| R44NS095423 | National Institutes of Health | FED | 93.853 | 2016 | $6,100,836 |
| SB1NS095423 | National Institutes of Health | FED | 93.853 | 2016 | $3,352,543 |
| R01FD007284 | Food and Drug Administration | FED | 93.103 | 2021 | $1,201,236 |
| R41HD094622 | National Institutes of Health | FED | 93.865 | 2018 | $224,998 |
Source: USASpending.gov federal award records. Federal awards only. Last checked 2026-09-07.